Global Autologous Fat Grafting Market 2021 by Company, Regions, Type and Application, Forecast to 2026


Mar, 2021 | Report ID: 173879 | 156 | Pharmaceuticals and Healthcare

The Autologous Fat Grafting market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Autologous Fat Grafting size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Autologous Fat Grafting market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Autologous Fat Grafting market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Integrated Fat Transfer Systems

Aspiration and Harvesting Systems

Liposuction Systems

Fat Processing Systems

De-Epithelialization Devices

Market segment by Application, can be divided into

Breast Augmentation

Buttock Augmentation

Facial Fat Grafting

Hand rejuvenation

Others

Market segment by players, this report covers

Allergan plc.

Cytori Therapeutics, Inc.

Sisram Medical, Ltd (Alma Lasers)

Genesis Biosystems, Inc

Black Tie Medical Inc. (Tulip Medical Inc.)

Ranfac Corp

HK Surgical Inc

Human Med AG

MicroAire Surgical Instruments, LLC

Sterimedix Ltd

Labtician Ophthalmics, Inc.

Innovia Medical Inc

Proteal Biogenerative Solutions.

Medikan International Inc

The GID Group, INC

Lipogems International SpA

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)


Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Autologous Fat Grafting

1.2 Classification of Autologous Fat Grafting by Type

1.2.1 Overview: Global Autologous Fat Grafting Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Autologous Fat Grafting Revenue Market Share by Type in 2020

1.2.3 Integrated Fat Transfer Systems

1.2.4 Aspiration and Harvesting Systems

1.2.5 Liposuction Systems

1.2.6 Fat Processing Systems

1.2.7 De-Epithelialization Devices

1.3 Global Autologous Fat Grafting Market by Application

1.3.1 Overview: Global Autologous Fat Grafting Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Breast Augmentation

1.3.3 Buttock Augmentation

1.3.4 Facial Fat Grafting

1.3.5 Hand rejuvenation

1.3.6 Others

1.4 Global Autologous Fat Grafting Market Size & Forecast

1.5 Global Autologous Fat Grafting Market Size and Forecast by Region

1.5.1 Global Autologous Fat Grafting Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Autologous Fat Grafting Market Size by Region, (2016-2021)

1.5.3 North America Autologous Fat Grafting Market Size and Prospect (2016-2026)

1.5.4 Europe Autologous Fat Grafting Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Autologous Fat Grafting Market Size and Prospect (2016-2026)

1.5.6 South America Autologous Fat Grafting Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Autologous Fat Grafting Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Autologous Fat Grafting Market Drivers

1.6.2 Autologous Fat Grafting Market Restraints

1.6.3 Autologous Fat Grafting Trends Analysis

2 Company Profiles

2.1 Allergan plc.

2.1.1 Allergan plc. Details

2.1.2 Allergan plc. Major Business

2.1.3 Allergan plc. Autologous Fat Grafting Product and Solutions

2.1.4 Allergan plc. Autologous Fat Grafting Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Allergan plc. Recent Developments and Future Plans

2.2 Cytori Therapeutics, Inc.

2.2.1 Cytori Therapeutics, Inc. Details

2.2.2 Cytori Therapeutics, Inc. Major Business

2.2.3 Cytori Therapeutics, Inc. Autologous Fat Grafting Product and Solutions

2.2.4 Cytori Therapeutics, Inc. Autologous Fat Grafting Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Cytori Therapeutics, Inc. Recent Developments and Future Plans

2.3 Sisram Medical, Ltd (Alma Lasers)

2.3.1 Sisram Medical, Ltd (Alma Lasers) Details

2.3.2 Sisram Medical, Ltd (Alma Lasers) Major Business

2.3.3 Sisram Medical, Ltd (Alma Lasers) Autologous Fat Grafting Product and Solutions

2.3.4 Sisram Medical, Ltd (Alma Lasers) Autologous Fat Grafting Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Sisram Medical, Ltd (Alma Lasers) Recent Developments and Future Plans

2.4 Genesis Biosystems, Inc

2.4.1 Genesis Biosystems, Inc Details

2.4.2 Genesis Biosystems, Inc Major Business

2.4.3 Genesis Biosystems, Inc Autologous Fat Grafting Product and Solutions

2.4.4 Genesis Biosystems, Inc Autologous Fat Grafting Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Genesis Biosystems, Inc Recent Developments and Future Plans

2.5 Black Tie Medical Inc. (Tulip Medical Inc.)

2.5.1 Black Tie Medical Inc. (Tulip Medical Inc.) Details

2.5.2 Black Tie Medical Inc. (Tulip Medical Inc.) Major Business

2.5.3 Black Tie Medical Inc. (Tulip Medical Inc.) Autologous Fat Grafting Product and Solutions

2.5.4 Black Tie Medical Inc. (Tulip Medical Inc.) Autologous Fat Grafting Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Black Tie Medical Inc. (Tulip Medical Inc.) Recent Developments and Future Plans

2.6 Ranfac Corp

2.6.1 Ranfac Corp Details

2.6.2 Ranfac Corp Major Business

2.6.3 Ranfac Corp Autologous Fat Grafting Product and Solutions

2.6.4 Ranfac Corp Autologous Fat Grafting Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Ranfac Corp Recent Developments and Future Plans

2.7 HK Surgical Inc

2.7.1 HK Surgical Inc Details

2.7.2 HK Surgical Inc Major Business

2.7.3 HK Surgical Inc Autologous Fat Grafting Product and Solutions

2.7.4 HK Surgical Inc Autologous Fat Grafting Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 HK Surgical Inc Recent Developments and Future Plans

2.8 Human Med AG

2.8.1 Human Med AG Details

2.8.2 Human Med AG Major Business

2.8.3 Human Med AG Autologous Fat Grafting Product and Solutions

2.8.4 Human Med AG Autologous Fat Grafting Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Human Med AG Recent Developments and Future Plans

2.9 MicroAire Surgical Instruments, LLC

2.9.1 MicroAire Surgical Instruments, LLC Details

2.9.2 MicroAire Surgical Instruments, LLC Major Business

2.9.3 MicroAire Surgical Instruments, LLC Autologous Fat Grafting Product and Solutions

2.9.4 MicroAire Surgical Instruments, LLC Autologous Fat Grafting Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 MicroAire Surgical Instruments, LLC Recent Developments and Future Plans

2.10 Sterimedix Ltd

2.10.1 Sterimedix Ltd Details

2.10.2 Sterimedix Ltd Major Business

2.10.3 Sterimedix Ltd Autologous Fat Grafting Product and Solutions

2.10.4 Sterimedix Ltd Autologous Fat Grafting Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Sterimedix Ltd Recent Developments and Future Plans

2.11 Labtician Ophthalmics, Inc.

2.11.1 Labtician Ophthalmics, Inc. Details

2.11.2 Labtician Ophthalmics, Inc. Major Business

2.11.3 Labtician Ophthalmics, Inc. Autologous Fat Grafting Product and Solutions

2.11.4 Labtician Ophthalmics, Inc. Autologous Fat Grafting Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Labtician Ophthalmics, Inc. Recent Developments and Future Plans

2.12 Innovia Medical Inc

2.12.1 Innovia Medical Inc Details

2.12.2 Innovia Medical Inc Major Business

2.12.3 Innovia Medical Inc Autologous Fat Grafting Product and Solutions

2.12.4 Innovia Medical Inc Autologous Fat Grafting Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Innovia Medical Inc Recent Developments and Future Plans

2.13 Proteal Biogenerative Solutions.

2.13.1 Proteal Biogenerative Solutions. Details

2.13.2 Proteal Biogenerative Solutions. Major Business

2.13.3 Proteal Biogenerative Solutions. Autologous Fat Grafting Product and Solutions

2.13.4 Proteal Biogenerative Solutions. Autologous Fat Grafting Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 Proteal Biogenerative Solutions. Recent Developments and Future Plans

2.14 Medikan International Inc

2.14.1 Medikan International Inc Details

2.14.2 Medikan International Inc Major Business

2.14.3 Medikan International Inc Autologous Fat Grafting Product and Solutions

2.14.4 Medikan International Inc Autologous Fat Grafting Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Medikan International Inc Recent Developments and Future Plans

2.15 The GID Group, INC

2.15.1 The GID Group, INC Details

2.15.2 The GID Group, INC Major Business

2.15.3 The GID Group, INC Autologous Fat Grafting Product and Solutions

2.15.4 The GID Group, INC Autologous Fat Grafting Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 The GID Group, INC Recent Developments and Future Plans

2.16 Lipogems International SpA

2.16.1 Lipogems International SpA Details

2.16.2 Lipogems International SpA Major Business

2.16.3 Lipogems International SpA Autologous Fat Grafting Product and Solutions

2.16.4 Lipogems International SpA Autologous Fat Grafting Revenue, Gross Margin and Market Share (2019-2021)

2.16.5 Lipogems International SpA Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Autologous Fat Grafting Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Autologous Fat Grafting Players Market Share

3.2.2 Top 10 Autologous Fat Grafting Players Market Share

3.2.3 Market Competition Trend

3.3 Autologous Fat Grafting Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Autologous Fat Grafting Revenue and Market Share by Type (2016-2021)

4.2 Global Autologous Fat Grafting Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Autologous Fat Grafting Revenue Market Share by Application (2016-2021)

5.2 Autologous Fat Grafting Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Autologous Fat Grafting Revenue by Type (2016-2026)

6.2 North America Autologous Fat Grafting Revenue by Application (2016-2026)

6.3 North America Autologous Fat Grafting Market Size by Country

6.3.1 North America Autologous Fat Grafting Revenue by Country (2016-2026)

6.3.2 United States Autologous Fat Grafting Market Size and Forecast (2016-2026)

6.3.3 Canada Autologous Fat Grafting Market Size and Forecast (2016-2026)

6.3.4 Mexico Autologous Fat Grafting Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Autologous Fat Grafting Revenue by Type (2016-2026)

7.2 Europe Autologous Fat Grafting Revenue by Application (2016-2026)

7.3 Europe Autologous Fat Grafting Market Size by Country

7.3.1 Europe Autologous Fat Grafting Revenue by Country (2016-2026)

7.3.2 Germany Autologous Fat Grafting Market Size and Forecast (2016-2026)

7.3.3 France Autologous Fat Grafting Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Autologous Fat Grafting Market Size and Forecast (2016-2026)

7.3.5 Russia Autologous Fat Grafting Market Size and Forecast (2016-2026)

7.3.6 Italy Autologous Fat Grafting Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Autologous Fat Grafting Revenue by Type (2016-2026)

8.2 Asia-Pacific Autologous Fat Grafting Revenue by Application (2016-2026)

8.3 Asia-Pacific Autologous Fat Grafting Market Size by Region

8.3.1 Asia-Pacific Autologous Fat Grafting Revenue by Region (2016-2026)

8.3.2 China Autologous Fat Grafting Market Size and Forecast (2016-2026)

8.3.3 Japan Autologous Fat Grafting Market Size and Forecast (2016-2026)

8.3.4 South Korea Autologous Fat Grafting Market Size and Forecast (2016-2026)

8.3.5 India Autologous Fat Grafting Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Autologous Fat Grafting Market Size and Forecast (2016-2026)

8.3.7 Australia Autologous Fat Grafting Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Autologous Fat Grafting Revenue by Type (2016-2026)

9.2 South America Autologous Fat Grafting Revenue by Application (2016-2026)

9.3 South America Autologous Fat Grafting Market Size by Country

9.3.1 South America Autologous Fat Grafting Revenue by Country (2016-2026)

9.3.2 Brazil Autologous Fat Grafting Market Size and Forecast (2016-2026)

9.3.3 Argentina Autologous Fat Grafting Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Autologous Fat Grafting Revenue by Type (2016-2026)

10.2 Middle East & Africa Autologous Fat Grafting Revenue by Application (2016-2026)

10.3 Middle East & Africa Autologous Fat Grafting Market Size by Country

10.3.1 Middle East & Africa Autologous Fat Grafting Revenue by Country (2016-2026)

10.3.2 Turkey Autologous Fat Grafting Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Autologous Fat Grafting Market Size and Forecast (2016-2026)

10.3.4 UAE Autologous Fat Grafting Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Autologous Fat Grafting Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Autologous Fat Grafting Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Autologous Fat Grafting Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Autologous Fat Grafting Revenue (USD Million) by Region (2016-2021)

Table 5. Global Autologous Fat Grafting Revenue Market Share by Region (2021-2026)

Table 6. Allergan plc. Corporate Information, Head Office, and Major Competitors

Table 7. Allergan plc. Major Business

Table 8. Allergan plc. Autologous Fat Grafting Product and Solutions

Table 9. Allergan plc. Autologous Fat Grafting Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Cytori Therapeutics, Inc. Corporate Information, Head Office, and Major Competitors

Table 11. Cytori Therapeutics, Inc. Major Business

Table 12. Cytori Therapeutics, Inc. Autologous Fat Grafting Product and Solutions

Table 13. Cytori Therapeutics, Inc. Autologous Fat Grafting Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Sisram Medical, Ltd (Alma Lasers) Corporate Information, Head Office, and Major Competitors

Table 15. Sisram Medical, Ltd (Alma Lasers) Major Business

Table 16. Sisram Medical, Ltd (Alma Lasers) Autologous Fat Grafting Product and Solutions

Table 17. Sisram Medical, Ltd (Alma Lasers) Autologous Fat Grafting Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Genesis Biosystems, Inc Corporate Information, Head Office, and Major Competitors

Table 19. Genesis Biosystems, Inc Major Business

Table 20. Genesis Biosystems, Inc Autologous Fat Grafting Product and Solutions

Table 21. Genesis Biosystems, Inc Autologous Fat Grafting Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Black Tie Medical Inc. (Tulip Medical Inc.) Corporate Information, Head Office, and Major Competitors

Table 23. Black Tie Medical Inc. (Tulip Medical Inc.) Major Business

Table 24. Black Tie Medical Inc. (Tulip Medical Inc.) Autologous Fat Grafting Product and Solutions

Table 25. Black Tie Medical Inc. (Tulip Medical Inc.) Autologous Fat Grafting Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Ranfac Corp Corporate Information, Head Office, and Major Competitors

Table 27. Ranfac Corp Major Business

Table 28. Ranfac Corp Autologous Fat Grafting Product and Solutions

Table 29. Ranfac Corp Autologous Fat Grafting Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. HK Surgical Inc Corporate Information, Head Office, and Major Competitors

Table 31. HK Surgical Inc Major Business

Table 32. HK Surgical Inc Autologous Fat Grafting Product and Solutions

Table 33. HK Surgical Inc Autologous Fat Grafting Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Human Med AG Corporate Information, Head Office, and Major Competitors

Table 35. Human Med AG Major Business

Table 36. Human Med AG Autologous Fat Grafting Product and Solutions

Table 37. Human Med AG Autologous Fat Grafting Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. MicroAire Surgical Instruments, LLC Corporate Information, Head Office, and Major Competitors

Table 39. MicroAire Surgical Instruments, LLC Major Business

Table 40. MicroAire Surgical Instruments, LLC Autologous Fat Grafting Product and Solutions

Table 41. MicroAire Surgical Instruments, LLC Autologous Fat Grafting Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Sterimedix Ltd Corporate Information, Head Office, and Major Competitors

Table 43. Sterimedix Ltd Major Business

Table 44. Sterimedix Ltd Autologous Fat Grafting Product and Solutions

Table 45. Sterimedix Ltd Autologous Fat Grafting Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Labtician Ophthalmics, Inc. Corporate Information, Head Office, and Major Competitors

Table 47. Labtician Ophthalmics, Inc. Major Business

Table 48. Labtician Ophthalmics, Inc. Autologous Fat Grafting Product and Solutions

Table 49. Labtician Ophthalmics, Inc. Autologous Fat Grafting Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Innovia Medical Inc Corporate Information, Head Office, and Major Competitors

Table 51. Innovia Medical Inc Major Business

Table 52. Innovia Medical Inc Autologous Fat Grafting Product and Solutions

Table 53. Innovia Medical Inc Autologous Fat Grafting Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Proteal Biogenerative Solutions. Corporate Information, Head Office, and Major Competitors

Table 55. Proteal Biogenerative Solutions. Major Business

Table 56. Proteal Biogenerative Solutions. Autologous Fat Grafting Product and Solutions

Table 57. Proteal Biogenerative Solutions. Autologous Fat Grafting Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Medikan International Inc Corporate Information, Head Office, and Major Competitors

Table 59. Medikan International Inc Major Business

Table 60. Medikan International Inc Autologous Fat Grafting Product and Solutions

Table 61. Medikan International Inc Autologous Fat Grafting Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. The GID Group, INC Corporate Information, Head Office, and Major Competitors

Table 63. The GID Group, INC Major Business

Table 64. The GID Group, INC Autologous Fat Grafting Product and Solutions

Table 65. The GID Group, INC Autologous Fat Grafting Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. Lipogems International SpA Corporate Information, Head Office, and Major Competitors

Table 67. Lipogems International SpA Major Business

Table 68. Lipogems International SpA Autologous Fat Grafting Product and Solutions

Table 69. Lipogems International SpA Autologous Fat Grafting Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 70. Global Autologous Fat Grafting Revenue (USD Million) by Players (2019-2021)

Table 71. Global Autologous Fat Grafting Revenue Share by Players (2019-2021)

Table 72. Breakdown of Autologous Fat Grafting by Company Type (Tier 1, Tier 2 and Tier 3)

Table 73. Autologous Fat Grafting Players Head Office, Products and Services Provided

Table 74. Autologous Fat Grafting Mergers & Acquisitions in the Past Five Years

Table 75. Autologous Fat Grafting New Entrants and Expansion Plans

Table 76. Global Autologous Fat Grafting Revenue (USD Million) by Type (2016-2021)

Table 77. Global Autologous Fat Grafting Revenue Share by Type (2016-2021)

Table 78. Global Autologous Fat Grafting Revenue Forecast by Type (2021-2026)

Table 79. Global Autologous Fat Grafting Revenue by Application (2016-2021)

Table 80. Global Autologous Fat Grafting Revenue Forecast by Application (2021-2026)

Table 81. North America Autologous Fat Grafting Revenue by Type (2016-2021) & (USD Million)

Table 82. North America Autologous Fat Grafting Revenue by Type (2021-2026) & (USD Million)

Table 83. North America Autologous Fat Grafting Revenue by Application (2016-2021) & (USD Million)

Table 84. North America Autologous Fat Grafting Revenue by Application (2021-2026) & (USD Million)

Table 85. North America Autologous Fat Grafting Revenue by Country (2016-2021) & (USD Million)

Table 86. North America Autologous Fat Grafting Revenue by Country (2021-2026) & (USD Million)

Table 87. Europe Autologous Fat Grafting Revenue by Type (2016-2021) & (USD Million)

Table 88. Europe Autologous Fat Grafting Revenue by Type (2021-2026) & (USD Million)

Table 89. Europe Autologous Fat Grafting Revenue by Application (2016-2021) & (USD Million)

Table 90. Europe Autologous Fat Grafting Revenue by Application (2021-2026) & (USD Million)

Table 91. Europe Autologous Fat Grafting Revenue by Country (2016-2021) & (USD Million)

Table 92. Europe Autologous Fat Grafting Revenue by Country (2021-2026) & (USD Million)

Table 93. Asia-Pacific Autologous Fat Grafting Revenue by Type (2016-2021) & (USD Million)

Table 94. Asia-Pacific Autologous Fat Grafting Revenue by Type (2021-2026) & (USD Million)

Table 95. Asia-Pacific Autologous Fat Grafting Revenue by Application (2016-2021) & (USD Million)

Table 96. Asia-Pacific Autologous Fat Grafting Revenue by Application (2021-2026) & (USD Million)

Table 97. Asia-Pacific Autologous Fat Grafting Revenue by Region (2016-2021) & (USD Million)

Table 98. Asia-Pacific Autologous Fat Grafting Revenue by Region (2021-2026) & (USD Million)

Table 99. South America Autologous Fat Grafting Revenue by Type (2016-2021) & (USD Million)

Table 100. South America Autologous Fat Grafting Revenue by Type (2021-2026) & (USD Million)

Table 101. South America Autologous Fat Grafting Revenue by Application (2016-2021) & (USD Million)

Table 102. South America Autologous Fat Grafting Revenue by Application (2021-2026) & (USD Million)

Table 103. South America Autologous Fat Grafting Revenue by Country (2016-2021) & (USD Million)

Table 104. South America Autologous Fat Grafting Revenue by Country (2021-2026) & (USD Million)

Table 105. Middle East & Africa Autologous Fat Grafting Revenue by Type (2016-2021) & (USD Million)

Table 106. Middle East & Africa Autologous Fat Grafting Revenue by Type (2021-2026) & (USD Million)

Table 107. Middle East & Africa Autologous Fat Grafting Revenue by Application (2016-2021) & (USD Million)

Table 108. Middle East & Africa Autologous Fat Grafting Revenue by Application (2021-2026) & (USD Million)

Table 109. Middle East & Africa Autologous Fat Grafting Revenue by Country (2016-2021) & (USD Million)

Table 110. Middle East & Africa Autologous Fat Grafting Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Autologous Fat Grafting Picture

Figure 2. Global Autologous Fat Grafting Revenue Market Share by Type in 2020

Figure 3. Integrated Fat Transfer Systems

Figure 4. Aspiration and Harvesting Systems

Figure 5. Liposuction Systems

Figure 6. Fat Processing Systems

Figure 7. De-Epithelialization Devices

Figure 8. Autologous Fat Grafting Revenue Market Share by Application in 2020

Figure 9. Breast Augmentation Picture

Figure 10. Buttock Augmentation Picture

Figure 11. Facial Fat Grafting Picture

Figure 12. Hand rejuvenation Picture

Figure 13. Others Picture

Figure 14. Global Autologous Fat Grafting Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 15. Global Autologous Fat Grafting Revenue and Forecast (2016-2026) & (USD Million)

Figure 16. Global Autologous Fat Grafting Revenue Market Share by Region (2016-2026)

Figure 17. Global Autologous Fat Grafting Revenue Market Share by Region in 2020

Figure 18. North America Autologous Fat Grafting Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. Europe Autologous Fat Grafting Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. Asia-Pacific Autologous Fat Grafting Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. South America Autologous Fat Grafting Revenue (USD Million) and Growth Rate (2016-2026)

Figure 22. Middle East and Africa Autologous Fat Grafting Revenue (USD Million) and Growth Rate (2016-2026)

Figure 23. Autologous Fat Grafting Market Drivers

Figure 24. Autologous Fat Grafting Market Restraints

Figure 25. Autologous Fat Grafting Market Trends

Figure 26. Allergan plc. Recent Developments and Future Plans

Figure 27. Cytori Therapeutics, Inc. Recent Developments and Future Plans

Figure 28. Sisram Medical, Ltd (Alma Lasers) Recent Developments and Future Plans

Figure 29. Genesis Biosystems, Inc Recent Developments and Future Plans

Figure 30. Black Tie Medical Inc. (Tulip Medical Inc.) Recent Developments and Future Plans

Figure 31. Ranfac Corp Recent Developments and Future Plans

Figure 32. HK Surgical Inc Recent Developments and Future Plans

Figure 33. Human Med AG Recent Developments and Future Plans

Figure 34. MicroAire Surgical Instruments, LLC Recent Developments and Future Plans

Figure 35. Sterimedix Ltd Recent Developments and Future Plans

Figure 36. Labtician Ophthalmics, Inc. Recent Developments and Future Plans

Figure 37. Innovia Medical Inc Recent Developments and Future Plans

Figure 38. Proteal Biogenerative Solutions. Recent Developments and Future Plans

Figure 39. Medikan International Inc Recent Developments and Future Plans

Figure 40. The GID Group, INC Recent Developments and Future Plans

Figure 41. Lipogems International SpA Recent Developments and Future Plans

Figure 42. Global Autologous Fat Grafting Revenue Share by Players in 2020

Figure 43. Autologous Fat Grafting Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 44. Global Top 3 Players Autologous Fat Grafting Revenue Market Share in 2020

Figure 45. Global Top 10 Players Autologous Fat Grafting Revenue Market Share in 2020

Figure 46. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 47. Global Autologous Fat Grafting Revenue Share by Type in 2020

Figure 48. Global Autologous Fat Grafting Market Share Forecast by Type (2021-2026)

Figure 49. Global Autologous Fat Grafting Revenue Share by Application in 2020

Figure 50. Global Autologous Fat Grafting Market Share Forecast by Application (2021-2026)

Figure 51. North America Autologous Fat Grafting Sales Market Share by Type (2016-2026)

Figure 52. North America Autologous Fat Grafting Sales Market Share by Application (2016-2026)

Figure 53. North America Autologous Fat Grafting Revenue Market Share by Country (2016-2026)

Figure 54. United States Autologous Fat Grafting Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. Canada Autologous Fat Grafting Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. Mexico Autologous Fat Grafting Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Europe Autologous Fat Grafting Sales Market Share by Type (2016-2026)

Figure 58. Europe Autologous Fat Grafting Sales Market Share by Application (2016-2026)

Figure 59. Europe Autologous Fat Grafting Revenue Market Share by Country (2016-2026)

Figure 60. Germany Autologous Fat Grafting Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. France Autologous Fat Grafting Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. United Kingdom Autologous Fat Grafting Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Russia Autologous Fat Grafting Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. Italy Autologous Fat Grafting Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. Asia-Pacific Autologous Fat Grafting Sales Market Share by Type (2016-2026)

Figure 66. Asia-Pacific Autologous Fat Grafting Sales Market Share by Application (2016-2026)

Figure 67. Asia-Pacific Autologous Fat Grafting Revenue Market Share by Region (2016-2026)

Figure 68. China Autologous Fat Grafting Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. Japan Autologous Fat Grafting Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. South Korea Autologous Fat Grafting Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. India Autologous Fat Grafting Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Southeast Asia Autologous Fat Grafting Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Australia Autologous Fat Grafting Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. South America Autologous Fat Grafting Sales Market Share by Type (2016-2026)

Figure 75. South America Autologous Fat Grafting Sales Market Share by Application (2016-2026)

Figure 76. South America Autologous Fat Grafting Revenue Market Share by Country (2016-2026)

Figure 77. Brazil Autologous Fat Grafting Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. Argentina Autologous Fat Grafting Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 79. Middle East and Africa Autologous Fat Grafting Sales Market Share by Type (2016-2026)

Figure 80. Middle East and Africa Autologous Fat Grafting Sales Market Share by Application (2016-2026)

Figure 81. Middle East and Africa Autologous Fat Grafting Revenue Market Share by Country (2016-2026)

Figure 82. Turkey Autologous Fat Grafting Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 83. Saudi Arabia Autologous Fat Grafting Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 84. UAE Autologous Fat Grafting Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 85. Methodology

Figure 86. Research Process and Data Source

Sample Request is not available